Fulgent Genetics Inc (FLGT)

Fulgent Genetics Inc Azioni (FLGT) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	5.88%90.41	85.39	71.14	83.34	84.07
Cost Of Revenue	2.09%58.47	59.71	49.65	50.75	48.56
Gross Profit	24.41%31.95	25.68	21.49	32.58	35.51
	11.75%54.49	61.75	56.11	68.82	50.86
Research and Development	6.31%13.64	14.55	14.18	14.17	13.86
Operating Income/Loss	37.50%-22.55	-36.07	-34.62	-36.24	-15.35
Nonoperating Income/Loss	33.23%8.50	6.38	8.64	6.96	7.84
Income/Loss From Continuing Operations Before Tax	52.70%-14.04	-29.69	-25.98	-29.27	-7.51
Income Tax Expense/Benefit, Deferred	172.22%0.07	-0.09	-1.12	-0.10	-0.86
Income Tax Expense/Benefit	2,528%-0.70	0.03	-0.70	-5.62	-0.68
	55.12%-13.34	-29.72	-25.27	-23.65	-6.83
Attributable To Parent	55.46%-13.15	-29.53	-24.83	-23.42	-6.61
Available To Common Stockholders, Basic	55.46%-13.15	-29.53	-24.83	-23.42	-6.61
Attributable To Noncontrolling Interest	1.06%-0.19	-0.19	-0.45	-0.23	-0.22
Basic Average Shares	1.22%27.66	28.01	30.88	0.07	30.75
Diluted Average Shares	1.22%27.66	28.01	30.88	0.07	30.75